Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking mycn amplification

International Journal of Cancer

Volumn 91, Issue 5, 2001, Pages 680-686

  Plantaz, D ^a,b   Vandesompele, J ^c,d,e   Van Roy, N ^e,f,g   Astowska, M ^h,i,j   Bown, N ^a,k   Combaret, V ^a   Favrot, M C ^a   Delattre, O ^a   Michon, J ^a   Benard J ^a   Hartmann, O ^a,b   Nicholson, J C ^a   Ross, F M ^c,d   Brinkschmidt, C ^a   Laureys, G ^a   Caron, H ^a   Matthay, K K ^a   Feuerstein, B G ^a   Speleman, F ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d CENTRE LÉON BÉRARD   (France)

^e INSTITUT CURIE   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITAL MÜNSTER   (Germany)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

11q deletion; 1p deletion; Comparative genomic hybridization; Genetic subgroup; MYCN; Stage 4 neuroblastoma

Indexed keywords

ARTICLE; CANCER STAGING; CHILD; CHROMOSOME 11Q; CHROMOSOME 1P; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 3; DISEASE-FREE SURVIVAL; FEMALE; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MODELS, GENETIC; MULTICENTER STUDIES; MUTATION; NEOPLASM METASTASIS; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0035283744     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1114>3.0.CO;2-R     Document Type: Article

References (28)

1. Human neuroblastoma tumour cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts
2. Neuroblastoma
3. Comparative genomic hybridization (CGH) analysis of neuroblastomas - An important methodological approach in pediatric tumour pathology
4. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group
5. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization
6. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization
7. Gain of chromosome arm 17q and adverse clinical outcome in neuroblastoma
8. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas
9. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
10. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization
11. Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization
12. Molecular biology and genetics of human neuroblastoma
13. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms
14. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas
15. Deletion of chromosome 11 and of 14q sequences in neuroblastoma
16. Allelotype of neuroblastoma
17. An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas
18. Deletion of 11q23 is a frequent event in the evolution of MYCN single copy, high-risk neuroblastomas
19. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells
20. Neuroblastoma in a boy with MCA/MR syndrome, deletion 11q, and duplication 12q
21. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma
22. Representational difference analysis and loss of heterozygosity studies detect 3p deletions in neuroblastoma
23. Loss of heterozygosity of 3p markers in neuroblastoma tumors implicate a tumour-suppressor locus distal to the FHIT gene
24. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high grade neuroblastomas
25. Relative prognostic value of genetic factors in neuroblastoma
26. Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridization analysis
27. SAGE profiles of neuroblastoma: Identification of MYCN downstream pathways
28. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid